AJR Am J Roentgenol

1. CHANG JM
   Enhancing Breast Cancer Screening by Human-Artificial Intelligence Collaboration: The Clinical Promise and Challenges.
   AJR Am J Roentgenol. 2025 Oct 15. doi: 10.2214/AJR.25.34018.
   

   >> Share

   
   

   
   Am J Clin Oncol

2. MCCLELLAND S 3RD, Burnette U, Onyewadume L, Smith TK, et al
   Impact of Patient Navigation on Radiation Therapy Completion in Black Breast Cancer Patients: Early Phase I Trial Results From the Navigator-Assisted Hypofractionation (NAVAH) Program.
   Am J Clin Oncol. 2025 Oct 15. doi: 10.1097/COC.0000000000001257.
   

   >> Share

   
   
3. HUANG Y, Ye D, Hassan F, Hart MJ, et al
   Efficacy and Safety of Antibody Drug Conjugates in Previously Treated Hormone Receptor Positive HER2 Negative (or Low) Metastatic Breast Cancer-A Systematic Review and Meta-Analysis.
   Am J Clin Oncol. 2025 Oct 14. doi: 10.1097/COC.0000000000001259.
   

   >> Share

   
   

   
   Am J Epidemiol

4. JONES RM, Han I, Hughes J, Nelson EJ, et al
   Assessing residential neighborhood exposomes and their associations with cancer incidence: rationale, study design, and methods.
   Am J Epidemiol. 2025;194:2977-2985.
   

   >> Share

   
   

   
   Am J Surg

5. POWELL M, Joseph KA
   When equal incidence isn't equal: Mortality gaps in breast cancer under 40.
   Am J Surg. 2025 Oct 6:116649. doi: 10.1016/j.amjsurg.2025.116649.
   

   >> Share

   
   

   
   Am J Surg Pathol

6. HSIAO WY, Nguyen TTA, Yang W, Yan H, et al
   Clinicopathologic and Whole Exome Sequencing Analyzes of High-Grade Serous Carcinoma-Like Carcinoma of the Breast Reveal Unique Genetic Profile and Poor Clinical Outcome.
   Am J Surg Pathol. 2025;49:1133-1142.
   

   >> Share

   
   

   
   Ann Oncol

7. GOETZ MP, Toi M, Huober J, Sohn J, et al
   Corrigendum to "Abemaciclib plus a nonsteroidal aromatase inhibitor as initial therapy for HR+, HER2- advanced breast cancer: final overall survival results of MONARCH 3": [Ann Oncol 2024; 35: 718-727].
   Ann Oncol. 2025 Oct 15:S0923-7534(25)00851-8. doi: 10.1016/j.annonc.2025.
   

   >> Share

   
   

   
   Ann Surg Oncol

8. DOUGLAS SR, Thomas SM, van den Bruele AB, Wang T, et al
   ASO Visual Abstract: Neoadjuvant Endocrine Therapy Use in Estrogen Receptor Positive Breast Cancer: Insights from Practice Shifts During the Covid-19 Pandemic.
   Ann Surg Oncol. 2025 Oct 15. doi: 10.1245/s10434-025-18495.
   

   >> Share

   
   

   
   BMC Cancer

9. GUO X, Gong X, Yang Y, Wang L, et al
   Circumferential periareolar incision length as a risk factor for skin necrosis after nipple-sparing mastectomy with deep inferior epigastric perforator flap reconstruction.
   BMC Cancer. 2025;25:1592.
   

   >> Share

   
   
10. LI Y, Long X, Xie Y, Zhong X, et al
    Tropomodulin 1 is essential for chemotherapy sensitivity and associated with better outcome in triple-negative breast cancer.
    BMC Cancer. 2025;25:1594.
    

    >> Share

    
    
11. SHARMA A, Johnson KB, Sen A, Bie B, et al
    Longitudinal multi-omics analyses of chemotherapy-induced peripheral neuropathy in response to taxanes.
    BMC Cancer. 2025;25:1591.
    

    >> Share

    
    
12. LI L, Yang P, Hong C, Chen D, et al
    Predictive value of tumor-infiltrating lymphocytes for neoadjuvant therapy response and prognosis in breast cancer: a multicenter retrospective study based on Chinese population.
    BMC Cancer. 2025;25:1585.
    

    >> Share

    
    
13. YAO G, Huang Y, Shang X, Guo L, et al
    Prediction of intraductal cancer microinfiltration based on the hierarchical fusion of peri-tumor imaging histology and dual view deep learning.
    BMC Cancer. 2025;25:1564.
    

    >> Share

    
    
14. OKAZAKI M, Ueda A, Iguchi-Manaka A, Mathis BJ, et al
    Refining compression therapy for the prevention of chemotherapy-induced peripheral neuropathy in breast cancer patients: a sub-analysis of patient-reported discomfort and usability.
    BMC Cancer. 2025;25:1567.
    

    >> Share

    
    
15. COSTA-PEREIRA JP, Macedo IF, Barbosa GA, Leitao GM, et al
    Myosteatosis is associated with advanced TNM stage and tumor features in young females with breast cancer.
    BMC Cancer. 2025;25:1576.
    

    >> Share

    
    
16. SCHAGERHOLM STANEV C, Sifakis EG, Hases L, Chen X, et al
    Transcriptomic profiles of endocrine-resistant breast cancer.
    BMC Cancer. 2025;25:1556.
    

    >> Share

    
    
17. SIMONYAN RM, Babayan MA, Yekmalyan HH, Simonyan SG, et al
    Thermostable enzyme isoforms, continuously producing monocomponent superoxide radicals, from human postoperative serous fluids: isolation and properties.
    BMC Cancer. 2025;25:1555.
    

    >> Share

    
    

    
    Br J Cancer

18. ZUCKER K, McInerney C, Glaser A, Baxter P, et al
    Why NHS hospital co-morbidity research may be wrong: how clinical coding fails to identify the impact of diabetes mellitus on cancer survival.
    Br J Cancer. 2025;133:1137-1144.
    

    >> Share

    
    
19. KRAMER CJH, van Wijk LM, Ruano D, Gelpke-Vermeulen S, et al
    Capturing breast cancers' copy-number landscape in routine pathology: Exploiting low-resolution, genome-wide sequencing to identify HRD and beyond.
    Br J Cancer. 2025;133:1199-1207.
    

    >> Share

    
    
20. FAN M, Wu X, Pan D, Du J, et al
    Multiscale Pancancer Analysis Uncovers Intrinsic Imaging and Molecular Characteristics Prominent in Breast Cancer and Glioblastoma.
    Br J Cancer. 2025 Oct 15. doi: 10.1038/s41416-025-03235.
    

    >> Share

    
    

    
    Breast Cancer

21. NISHINA T, Tanioka M, Takada K, Tsukioki T, et al
    Clinical significance on switching CDK4/6 inhibitors among 13,284 patients with metastatic breast cancer.
    Breast Cancer. 2025 Oct 12. doi: 10.1007/s12282-025-01768.
    

    >> Share

    
    
22. DE PASQUALE G, Donatiello V, Lucarelli M, Bonelli R, et al
    Is there an impact of autoimmune rheumatological diseases on cutaneous toxicity in breast cancer adjuvant radiotherapy? A mono-institutional experience.
    Breast Cancer. 2025 Oct 13. doi: 10.1007/s12282-025-01791.
    

    >> Share

    
    

    
    Breast Cancer (Dove Med Press)

23. WEI W, Xia F, Zhou W, Lu W, et al
    Ki-67 Prediction in Breast Cancer: Integrating Radiomics From Automated Breast Volume Scanner and 2D Ultrasound Images via Machine Learning.
    Breast Cancer (Dove Med Press). 2025;17:897-912.
    

    >> Share

    
    

    
    Breast Cancer Res

24. ZHANG R, Wang K, Wang S, Wang C, et al
    Multimodal deep learning model for prediction of breast cancer recurrence risk and correlation with oncotype DX.
    Breast Cancer Res. 2025;27:178.
    

    >> Share

    
    
25. CAO A, Fumagalli IA, Chen WY, Llanos AAM, et al
    Association between thoracic adiposity and survival in non-metastatic breast cancer.
    Breast Cancer Res. 2025;27:176.
    

    >> Share

    
    
26. LIEN HC, Li YC, Yun-Ju Huang R, Chen KC, et al
    Carcinomas exhibiting epithelial-mesenchymal transition manifest an M2 macrophage-enriched tumor immune microenvironment.
    Breast Cancer Res. 2025;27:177.
    

    >> Share

    
    
27. MARCHENKO N, Nesbitt NM, Alexandrova E, Reisz JA, et al
    Biliverdin reductase B as a new target in breast cancer.
    Breast Cancer Res. 2025;27:179.
    

    >> Share

    
    

    
    Breast Cancer Res Treat

28. AMITANI M, Oba T, Kitazawa A, Iji R, et al
    Prognostic significance of baseline skeletal muscle index and its dynamics in patients with metastatic breast cancer undergoing eribulin treatment.
    Breast Cancer Res Treat. 2025 Oct 15. doi: 10.1007/s10549-025-07827.
    

    >> Share

    
    

    
    Breast J

29. SORENSON TJ, Boyd CJ, Park JJ, Hemal K, et al
    Nipple Areolar Complex (NAC) Neurotization After Nipple-Sparing Mastectomy (NSM) in Implant-Based Breast Reconstruction: A Systematic Review of the Literature.
    Breast J. 2025;2025:2362697.
    

    >> Share

    
    

    
    Carcinogenesis

30. PARSYAN A, Athwal H, Bhat V, Allan AL, et al
    Polo-like Kinase 4 (PLK4) as a Therapeutic Target in Breast Cancer.
    Carcinogenesis. 2025 Oct 14:bgaf067. doi: 10.1093.
    

    >> Share

    
    

    
    Clin Breast Cancer

31. APHALE P, Dokania S, Shekhar H
    Comment on "Long-Term Safety and Efficacy of the Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Injection in Patients With HER2-Positive Early Breast Cancer in PHranceSCa, a Randomized, Open-Label Phase II Study".
    Clin Breast Cancer. 2025 Sep 21:S1526-8209(25)00280.
    

    >> Share

    
    
32. CHAMAN R, Welsh JS, Khatibmasjedi S, Mohammadkhani M, et al
    Editorial for "Real World Safety of Adjuvant Ultra Hypofractionated Radiotherapy in Nonmetastatic Breast Cancer: Acute Cutaneous Toxicity and Aesthetic Outcomes".
    Clin Breast Cancer. 2025 Sep 18:S1526-8209(25)00278.
    

    >> Share

    
    
33. KINOWAKI K, Takeiwa T, Ikeda K, Fujimoto A, et al
    Positive Immunoreactivities of TM9SF1 and EBAG9 are Associated With Poor Prognosis in Patients With Triple-Negative Breast Cancer.
    Clin Breast Cancer. 2025 Sep 17:S1526-8209(25)00276.
    

    >> Share

    
    
34. SANLI AN, Tekcan Sanli DE
    Refining Prognostic Tools for Young Breast Cancer: Practical and Methodological Concerns.
    Clin Breast Cancer. 2025 Sep 16:S1526-8209(25)00274.
    

    >> Share

    
    

    
    Clin Exp Metastasis

35. CORONADO-ALVARADO CD, Astiazaran-Garcia H
    Defining the Tumor-Bone axis: the role of extracellular vesicles in a crucial exchange route for breast cancer development and progression.
    Clin Exp Metastasis. 2025;42:59.
    

    >> Share

    
    

    
    Eur J Surg Oncol

36. WANG Y, Zhan J, Liu S, Chen M, et al
    Impact of COVID-19 on neoadjuvant chemotherapy efficacy in patients with breast cancer: An ambidirectional cohort study and mendelian randomization analysis.
    Eur J Surg Oncol. 2025;51:110496.
    

    >> Share

    
    

    
    Int J Cancer

37. CHEPTEA C, Loap P, Allali S, Fourquet A, et al
    Optimizing the integration of modern systemic therapies and advanced radiotherapy techniques in breast cancer management: An expert opinion from the Institut Curie Breast Radiotherapy Group.
    Int J Cancer. 2025 Oct 11. doi: 10.1002/ijc.70190.
    

    >> Share

    
    

    
    Int J Oncol

38. JIN ML, Park SY, Kim YH, Park G, et al
    [Expression of Concern] Halofuginone induces the apoptosis of breast cancer cells and inhibits migration via downregulation of matrix metalloproteinase?9.
    Int J Oncol. 2025;67:106.
    

    >> Share

    
    

    
    Int J Radiat Oncol Biol Phys

39. VICINI F, Shah C, Mittal K, Weinmann S, et al
    Limitations in the Application of Clinicopathologic Factors Alone in Predicting Radiation Benefit for Women With Low-Risk Ductal Carcinoma In Situ After Breast Conserving Surgery: The Impact of a 7-Gene Biosignature Based on 10-Year Ipsilateral Breast
    Int J Radiat Oncol Biol Phys. 2025;123:1090-1101.
    

    >> Share

    
    

    
    J Clin Oncol

40. LIN JK, Niu J, Giordano SH, Li P, et al
    Racial and Ethnic Disparities Along the Treatment Cascade Among Medicare Fee-for-Service Beneficiaries With Metastatic Breast, Colorectal, Lung, and Prostate Cancers.
    J Clin Oncol. 2025;43:3254-3265.
    

    >> Share

    
    
41. JIMENEZ RB, Abdou Y, Anderson P, Barry P, et al
    Postmastectomy Radiation Therapy: An ASTRO-ASCO-SSO Clinical Practice Guideline.
    J Clin Oncol. 2025;43:3292-3311.
    

    >> Share

    
    
42. KAVIANI A, Bourque JM, Farazmand B, Salmon RJ, et al
    Beyond the Trials: Real-World Considerations for Sentinel Lymph Node Biopsy Omission in Early Breast Cancer.
    J Clin Oncol. 2025 Oct 13:JCO2501630. doi: 10.1200/JCO-25-01630.
    

    >> Share

    
    

    
    J Natl Cancer Inst

43. NADER-MARTA G, Chu X, Mukhopadhyay S, Abramson VG, et al
    Prognostic value of visually and computationally-assessed tumor-infiltrating lymphocytes in early-stage triple-negative breast cancer (TBCRC-030).
    J Natl Cancer Inst. 2025 Oct 11:djaf289. doi: 10.1093.
    

    >> Share

    
    
44. OTTAVIANI D, Ola M, Allotta A, Maati Chaibi Y, et al
    Targeting CDK12 disrupts estrogen-receptor chromatin recruitment and ER-MED1 transcription in advanced ER+ breast cancer.
    J Natl Cancer Inst. 2025 Oct 15:djaf295. doi: 10.1093.
    

    >> Share

    
    
45. 
    Correction to: Discovering plasma proteins associated with breast cancer incidence in postmenopausal women in the Atherosclerosis Risk in Communities study.
    J Natl Cancer Inst. 2025 Oct 17:djaf284. doi: 10.1093.
    

    >> Share

    
    

    
    J Surg Oncol

46. GHOSH K, Kuchta K, Alva D, Seth AK, et al
    Is Prepectoral Implant Reconstruction Associated With Better Physical Well-Being?
    J Surg Oncol. 2025;132:1071-1075.
    

    >> Share

    
    
47. GOLDHABER NH, O'Keefe TJ, Longo L, Blair SL, et al
    Effect of Neoadjuvant Hormonal Therapy on Breast Conservation in Invasive Ductal Versus Lobular Carcinoma of the Breast: A Comparative Analysis.
    J Surg Oncol. 2025;132:1011-1018.
    

    >> Share

    
    

    
    PLoS Med

48. WALKER AE, Gao X, Wang Q, De la Cruz G, et al
    Prognostic significance of CD8+ T cell Spatial Biomarkers in ER+ and ER- breast cancer: A retrospective cohort study.
    PLoS Med. 2025;22:e1004647.
    

    >> Share

    
    

    
    PLoS One

49. LESER C, Kabashi F, Dorffner G, Zaric O, et al
    Exploring the role of routine brain imaging in detecting asymptomatic brain metastases in first diagnosed HER2-positive breast cancer.
    PLoS One. 2025;20:e0334610.
    

    >> Share

    
    
50. GUEVARA-NIETO HM, Orozco-Castano CA, Parra-Medina R, Poveda-Garavito JN, et al
    Molecular determinants of neoadjuvant chemotherapy resistance in breast cancer: An analysis of gene expression and tumor microenvironment.
    PLoS One. 2025;20:e0334335.
    

    >> Share

    
    
51. ZHANG Z, Li Y, Huang H, Wei T, et al
    Disparities and trends of the incidence and mortality of female-specific cancers in the United States.
    PLoS One. 2025;20:e0334128.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

52. ERDOGMUS S, Srinivas N, Mollaoglu G
    Guardians at the border: Peritumoral macrophages fight breast cancer.
    Proc Natl Acad Sci U S A. 2025;122:e2523640122.
    

    >> Share

    
    

    
    Radiol Artif Intell

53. KIM EY, Park EK, Kwon MR, Kim M, et al
    Radiologist and AI Concordance in Screening Mammography and Association with Future Breast Cancer Risk.
    Radiol Artif Intell. 2025 Oct 15:e240804. doi: 10.1148/ryai.240804.
    

    >> Share

    
    

    
    Radiol Imaging Cancer

54. WANG XY, Huang JX, Liu FT, Huang HN, et al
    Predicting Breast Cancer Pathologic Complete Response after Neoadjuvant Chemotherapy Using Bimodal US and MRI.
    Radiol Imaging Cancer. 2025;7:e240493.
    

    >> Share

    
    
55. HORVAT JV, Fazzio RT
    Elastography and MRI for the Evaluation of Complete Response to Neoadjuvant Therapy for Breast Cancer.
    Radiol Imaging Cancer. 2025;7:e250504.
    

    >> Share

    
    

    
    Radiology

56. COHEN EO, Tso HH, Shin K, Martaindale SR, et al
    Feasibility of Auditing Preoperative Breast MRI for Extent-of-Disease Evaluation Using the BI-RADS v2025 Manual.
    Radiology. 2025;317:e243803.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share